Investor Relations

News Releases

Date Title and Summary Additional Formats
Toggle Summary Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
Company Expands Aesthetic Franchise with New Product Used to Treat Fine Lines and Wrinkles Plans European Launch in Early 2010
View HTML
Toggle Summary Anika Therapeutics Reports 17% Revenue Growth in Third-Quarter 2009
Net Income Increases 37%
View HTML
Toggle Summary Anika Therapeutics Announces Date of Third Quarter 2009 Financial Results Conference Call
Anika Therapeutics Announces Date of Third Quarter 2009 Financial Results Conference Call BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 13, 2009-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its third-quarter 2009 financial results after the close of the market on
View HTML
Toggle Summary Anika Therapeutics Receives Health Canada Approval for MONOVISC™
Represents the first approval in North America for its Single-Injection Osteoarthritis Treatment
View HTML
Toggle Summary Anika Therapeutics Reports Second-Quarter 2009 Results
Domestic Unit Sales of ORTHOVISC(R) Grow to Record Quarterly Level
View HTML
Toggle Summary Anika Therapeutics Announces Date of Second Quarter 2009 Financial Results Conference Call
Anika Therapeutics Announces Date of Second Quarter 2009 Financial Results Conference Call BEDFORD, Mass. --(BUSINESS WIRE)--Jul. 15, 2009-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its second-quarter 2009 financial results after the close of the market on
View HTML
Toggle Summary Anika Therapeutics Announces U.S. Distribution Agreement with Facial Aesthetics Provider Coapt Systems for Aesthetic Dermatology Franchise
Anika Gains Access to Coapt Systems' Experienced Technical Sales Force
View HTML
Toggle Summary Anika Therapeutics Appoints Frank J. Luppino as Chief Operating Officer
Seasoned Operations Executive Returns to Company
View HTML
Toggle Summary Anika Therapeutics Reports First Quarter 2009 Results
Revenues Rise 8% Led By Strong ORTHOVISC(R) Sales Growth
View HTML
Toggle Summary Anika Therapeutics Announces Date of First Quarter 2009 Financial Results Conference Call
Anika Therapeutics Announces Date of First Quarter 2009 Financial Results Conference Call BEDFORD, Mass. --(BUSINESS WIRE)--Apr. 23, 2009-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2009 financial results after the close of the market on
View HTML